Johnson & Johnson’s Biosense Webster announced today that the FDA approved several products in its cardiac ablation portfolio for zero fluoroscopy workflow. Products that received approval include the ThermoCool SmartTouch SF catheter, the most commonly used ablation catheter for radiofrequency ablation. The portfolio’s approved products also include the standard ThermoCool SmartTouch and Carto Vizigo bi-directional […]
Johnson & Johnson
Johnson & Johnson looks to split off Kenvue, focus on MedTech and Pharma
Johnson & Johnson today announced its intention to split off at least 80.1% of the shares of Kenvue. The New Brunswick, New Jersey-based company plans for the separation of its former consumer health business to take place through an exchange offer. Kenvue completed its IPO in May 2023. Through the planned exchange offer, Johnson & […]
J&J’s Biosense Webster launches AFib mapping catheter
Johnson & Johnson’s Biosense Webster announced today that it launched the Optrell mapping catheter with TrueRef technology. Irvine, California-based Biosense Webster designed Optrell as a high-density diagnostic catheter powered by its Carto 3 system. It features small electrodes arranged in a fixed array formation. These provide high-definition electrophysiological mapping of complex cardiac arrhythmia cases. Optrell […]
Johnson & Johnson posts Street-beating Q2, raises guidance
Johnson & Johnson shares are up today on second-quarter results that topped the consensus forecast. Shares of JNJ rose more than 5% to $159.50 apiece in morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up slightly. The New Brunswick, New Jersey-based company posted […]
J&J’s Abiomed recalls Impella again — this time it’s TAVR-related
Johnson & Johnson’s Abiomed unit issued another recall for some of its Impella heart pumps. FDA communications dated July 14 confirmed the second recall in a month for certain Impella products. In June, the company recalled 466 Impella 5.5 with SmartAssist devices. Abiomed initiated that recall after receiving complaints relating to purge fluid leaking from […]
J&J’s Ethicon has a serious Megadyne electrode recall due to potential burns in electrosurgery
The FDA labeled a recall of Megadyne electrode products manufactured by Johnson & Johnson’s Ethicon Class I, the most serious kind. Recalled products include a number of Megadyne Mega Soft electrodes and the Mega 2000 patient return electrode. Ethicon paid an undisclosed amount to acquire Megadyne Medical Products in 2017 after several years of collaboration. […]
Former DePuy Synthes sales rep accused of defrauding Boston area hospital
Federal prosecutors claim a former DePuy Synthes sales representative defrauded an undisclosed Boston area hospital, with hundreds of thousands of dollars worth of spine products involved. According to a federal grand jury indictment announced this week in Massachusetts, Matthew Capobianco falsely represented on usage forms that more—and more expensive—Johnson & Johnson DePuy products were used […]
GE HealthCare and DePuy Synthes are partnering in spine surgery
GE HealthCare has been on a tear announcing major partnerships. Today, it announced its latest — with Johnson & Johnson’s DePuy Synthes ortho device business. The distribution agreement involves bringing GE HealthCare’s OEC 3D Imaging System, in conjunction with DePuy Synthes’ extensive product portfolio, to more spine surgeons and patients across the United States. The […]
Abiomed recalls some Impella 5.5 with SmartAssist devices
The FDA today issued a field safety notice deeming a recall of Abiomed Impella 5.5 heart pumps as Class I, the most serious kind. Abiomed — bought by Johnson & Johnson for $16.6 billion last year — recalled 466 affected devices. It distributed these Impella 5.5 with SmartAssist devices between Sept. 28, 2021, and March […]
J&J’s Biosense Webster gets a new president
Johnson & Johnson’s Biosense Webster this week announced it appointed Jasmina Brooks as president. As president, Brooks will be responsible for setting Biosense Webster’s global strategy and advancing its innovation agenda to position the company for continued growth. Brooks succeeds Michael Bodner, who is now the global head of heart recovery for J&J MedTech. She […]
Data supports Biosense Webster RF ablation for treating AFib
Johnson & Johnson MedTech’s Biosense Webster today announced data from a study of its QDOT Micro catheter for treating AFib. JACC: Clinical Electrophysiology published data from the Q-FFICIENCY study evaluating QDOT Micro’s safety and 12-month effectiveness. The study observed the use of the catheter in paroxysmal AFib ablation using a combination of high-power and conventional modes. […]